Quest Diagnostics ROE 2010-2024 | DGX

Current and historical return on equity (ROE) values for Quest Diagnostics (DGX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Quest Diagnostics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.84B $6.84B 12.74%
2024-06-30 $0.84B $6.66B 12.90%
2024-03-31 $0.84B $6.47B 13.18%
2023-12-31 $0.85B $6.34B 13.50%
2023-09-30 $0.76B $6.46B 12.24%
2023-06-30 $0.79B $6.29B 12.87%
2023-03-31 $0.79B $6.09B 12.76%
2022-12-31 $0.94B $5.93B 15.03%
2022-09-30 $1.23B $6.27B 19.16%
2022-06-30 $1.48B $6.45B 22.90%
2022-03-31 $1.87B $6.42B 29.66%
2021-12-31 $1.99B $6.48B 31.01%
2021-09-30 $2.18B $6.43B 33.55%
2021-06-30 $2.24B $5.94B 34.50%
2021-03-31 $1.80B $6.79B 27.69%
2020-12-31 $1.43B $6.81B 22.95%
2020-09-30 $1.11B $6.45B 18.64%
2020-06-30 $0.75B $5.88B 13.12%
2020-03-31 $0.79B $5.70B 14.06%
2019-12-31 $0.86B $5.69B 15.47%
2019-09-30 $0.73B $5.65B 13.45%
2019-06-30 $0.73B $5.51B 13.59%
2019-03-31 $0.72B $5.34B 13.62%
2018-12-31 $0.74B $5.27B 14.05%
2018-09-30 $0.86B $5.37B 16.72%
2018-06-30 $0.81B $5.26B 16.13%
2018-03-31 $0.79B $5.07B 16.04%
2017-12-31 $0.77B $4.96B 16.10%
2017-09-30 $0.67B $4.83B 14.19%
2017-06-30 $0.70B $4.73B 14.95%
2017-03-31 $0.70B $4.66B 15.13%
2016-12-31 $0.64B $4.66B 13.81%
2016-09-30 $0.68B $4.69B 14.48%
2016-06-30 $0.83B $4.57B 17.77%
2016-03-31 $0.75B $4.67B 16.31%
2015-12-31 $0.71B $4.71B 15.73%
2015-09-30 $0.71B $4.62B 16.19%
2015-06-30 $0.50B $4.34B 11.61%
2015-03-31 $0.51B $4.27B 12.12%
2014-12-31 $0.56B $4.33B 13.33%
2014-09-30 $0.51B $4.21B 12.47%
2014-06-30 $0.79B $4.12B 19.64%
2014-03-31 $0.82B $4.02B 20.68%
2013-12-31 $0.85B $3.97B 21.21%
2013-09-30 $0.76B $3.87B 18.79%
2013-06-30 $0.52B $3.94B 12.57%
2013-03-31 $0.53B $4.23B 12.82%
2012-12-31 $0.56B $4.19B 13.64%
2012-09-30 $0.69B $4.20B 17.44%
2012-06-30 $0.70B $4.02B 18.42%
2012-03-31 $0.68B $3.90B 18.73%
2011-12-31 $0.47B $3.72B 13.51%
2011-09-30 $0.45B $3.55B 12.51%
2011-06-30 $0.47B $3.45B 12.94%
2011-03-31 $0.51B $3.24B 13.36%
2010-12-31 $0.72B $4.05B 18.24%
2010-09-30 $0.74B $3.88B 18.70%
2010-06-30 $0.73B $3.95B 18.48%
2010-03-31 $0.72B $3.93B 18.51%
2009-12-31 $0.73B $4.01B 19.13%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $18.048B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.749B 11.95
DaVita (DVA) United States $12.959B 16.76
Encompass Health (EHC) United States $10.338B 24.37
Chemed (CHE) United States $8.511B 26.16
Elanco Animal Health (ELAN) United States $6.980B 16.61
RadNet (RDNT) United States $6.182B 137.03
Option Care Health (OPCH) United States $3.889B 18.43
Amedisys (AMED) United States $2.980B 21.21
LifeStance Health (LFST) United States $2.832B 0.00
Addus HomeCare (ADUS) United States $2.287B 26.84
Astrana Health (ASTH) United States $2.106B 33.01
U.S Physical Therapy (USPH) United States $1.390B 36.55
Pennant (PNTG) United States $1.156B 46.74
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Atai Life Sciences (ATAI) Germany $0.245B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.013B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00